Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,352Revenue $M1.4Net Margin (%)-2,456.1Z-Score32.2
Enterprise Value $M1,306EPS $-0.3Operating Margin %-3,213.6F-Score3
P/E(ttm))0Cash Flow Per Share $-0.7Pre-tax Margin (%)-2,456.1Higher ROA y-yN
Price/Book32.810-y EBITDA Growth Rate %-11.6Quick Ratio4.1Cash flow > EarningsN
Price/Sales8685-y EBITDA Growth Rate %1.6Current Ratio4.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-56.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-89.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M103ROI % (ttm)-167.5Gross Margin Increase y-yN

Gurus Latest Trades with ZIOP

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZIOPJean-Marie Eveillard 2013-06-30 Sold Out $1.52 - $2.621
($1.85)
$ 11.79537%Sold Out0
ZIOPJean-Marie Eveillard 2013-03-31 Buy $1.72 - $5.71
($4.42)
$ 11.79167%New holding, 200000 sh.200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZIOP is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ZIOP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIRK RANDAL JDirector, 10% Owner 2015-02-09Buy1,440,000$8.7528.69view
KIRK RANDAL JDirector, 10% Owner 2013-10-29Buy2,857,143$3.5221.71view
KIRK RANDAL JDirector, 10% Owner 2012-01-20Buy1,923,075$5.2116.54view
KIRK RANDAL JDirector, 10% Owner 2011-08-23Buy38,294$4.99125.65view
KIRK RANDAL JDirector, 10% Owner 2011-08-22Buy461,646$4.92128.86view
Fowler WycheDirector 2011-08-10Buy5,000$5.19116.96view
KIRK RANDAL JDirector, 10% Owner 2011-08-09Buy846,522$4.78135.56view
WEISER MICHAELDirector 2011-05-25Sell15,000$6.5372.43view
BRENNAN MURRAYDirector 2011-05-09Sell15,000$6.5771.39view
KIRK RANDAL JDirector, 10% Owner 2011-02-03Buy1,910,000$5.7595.83view

Press Releases about ZIOP :

    Quarterly/Annual Reports about ZIOP:

    News about ZIOP:

    Articles On GuruFocus.com
    Hayman Advisors Update - Second Quarter Sells and Company Results Aug 26 2013 
    Bass’ New Buy – ZIOPHARM Oncology Inc. May 16 2013 
    The Far-Off Four, 52-week Lows Held by Gurus May 11 2013 
    comment on ZIOP Mar 15 2013 
    cooldecency99 note on ZIOP May 01 2010 
    ZIOPHARM Reports Second Quarter Financial Results and Updates Clinical Programs Aug 14 2009 

    More From Other Websites
    FireEye, 3 More Are Hot Momentum Stocks Despite Overheated Market Feb 27 2015
    Ziopharm reports 4Q loss Feb 27 2015
    Ziopharm reports 4Q loss Feb 27 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 26 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 10-K, Annual Report Feb 26 2015
    ZIOPHARM Reports Fourth-Quarter and Full-Year 2014 Financial Results and Recent Activities Feb 26 2015
    Double trouble: Unusual activity in ZIOP, MCD & GRPN Feb 26 2015
    Bullish Traders Take Another Dose of Ziopharm Oncology Feb 24 2015
    Another bullish dose of Ziopharm Feb 24 2015
    What Investors Should Expect From Janet Yellen’s Testimony on Tuesday Feb 23 2015
    Four trades to go before the closing bell Feb 23 2015
    FMHR Final Trade: SLXP, NEM, DE & ZIOP Feb 23 2015
    Our ZIOP Read Feb 23 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial... Feb 12 2015
    ZIOPHARM Oncology Announces Exercise of Option to Purchase Additional Shares Feb 12 2015
    ZIOPHARM to Present at the 17th Annual BIO CEO & Investor Conference Feb 05 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Feb 04 2015
    ZIOPHARM Oncology Announces Pricing of Public Offering of Common Stock Feb 03 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation... Feb 02 2015
    ZIOPHARM Oncology Announces Proposed Public Offering of Common Stock Feb 02 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK